Synagis INN-palivizumab;
hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk The most serious adverse reactions occurring with palivizumab are ...
synagis epar product information en
Palivizumab (Synagis®) for RSV Infection
infection caused by respiratory syncytial virus (RSV). What is RSV? RSV is an extremely Are there any side effects or complications from the injections?
Ppalivizumab
Synagis updated EPAR summary II-92
Synagis palivizumab. This is a summary of the European public assessment report The most common side effects with Synagis (seen in between 1 and 10 ...
synagis epar summary public en
Reference ID: 3111266
Synagis is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal To report SUSPECTED ADVERSE REACTIONS contact MedImmune.
s lbl
Aide-mémoire pour l'administration du Palivizumab (Synagis) aux
Refer to the current administration schedule. Informed consent. • Information on RSV. • Information on the benefits and side effects of. Synagis.
aide memoire vrs
Synagis® (palivizumab) injection for intramuscular use
Synagis is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal The most serious adverse reactions occurring with Synagis are anaphylaxis ...
s lbl
PATIENT MEDICATION INFORMATION READ THIS FOR SAFE
24 févr. 2022 SYNAGIS is not used to treat the symptoms of RSV disease once a child already has it ... Like all medicines SYNAGIS can cause side effects.
synagis consumer information leaflet en
INFORMATION FOR PARENTS CONCERNING PALIVIZUMAB
INFORMATION À L'INTENTION. DES PARENTS CONCERNANT LE PALIVIZUMAB (SYNAGIS) Potential side effects of Palivizumab (less than 1% of cases).
depliant info parents fr
Synagis - Palivizumab
hospitalisation caused by respiratory syncytial virus (RSV) in children at high Within each frequency grouping adverse reactions have been presented in ...
anx en
PP-8593 HIGHLIGHTS OF PRESCRIBING INFORMATION These
Synagis is a respiratory syncytial virus (RSV) F protein inhibitor Adverse reactions occurring greater than or equal to 10% and at least 1% more.
synagis
- palivizumab (synagis) side effects